2016
DOI: 10.1136/neurintsurg-2016-012263.rep
|View full text |Cite
|
Sign up to set email alerts
|

Republished: Novel balloon application for rescue and realignment of a proximal end migrated pipeline flex embolization device into the aneurysmal sac: complication management

Abstract: The pipeline embolization device (PED) has become a routine firstline option for the treatment of an increasing population of intracranial aneurysms at many neurovascular centers. Intraprocedural complications during PED deployment, or complications associated with migration of the device, are rarely reported problems. Significant mismatch in luminal diameter between the inflow vessel and the outflow vessel or excessive dragging-stretching of the PED have been related to 'watermelon seed' or 'accordion' effect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 11 publications
0
12
0
Order By: Relevance
“… 1 2 The Pipeline Embolization Device (PED; Medtronic Neurovascular, Irvine, California, USA) has become a routine first-line treatment option for an increasing patient population with IAs. 1 3 The first-generation PED device, used for the embolization of cerebral aneurysms, received European CE mark approval in 2008 and US FDA approval in 2011. 4 Its safety and efficacy have been demonstrated in numerous clinical studies, such as the Pipeline for Uncoilable and Failed Aneurysms (PUFS) trial, 5 the International Retrospective Study of PED (IntrePED), 6 the Aneurysm Study of Pipeline in an Observational Registry (ASPIRe) study, 7 and several large clinical series.…”
Section: Introductionmentioning
confidence: 99%
“… 1 2 The Pipeline Embolization Device (PED; Medtronic Neurovascular, Irvine, California, USA) has become a routine first-line treatment option for an increasing patient population with IAs. 1 3 The first-generation PED device, used for the embolization of cerebral aneurysms, received European CE mark approval in 2008 and US FDA approval in 2011. 4 Its safety and efficacy have been demonstrated in numerous clinical studies, such as the Pipeline for Uncoilable and Failed Aneurysms (PUFS) trial, 5 the International Retrospective Study of PED (IntrePED), 6 the Aneurysm Study of Pipeline in an Observational Registry (ASPIRe) study, 7 and several large clinical series.…”
Section: Introductionmentioning
confidence: 99%
“…In this situation, a Hyperform TM balloon was useful for moving the stent and changing its direction. 6) The over-length stent might also induce this situation. On planning the telescoping stents, we tend to select the longest stent to save the number of stents.…”
Section: Discussionmentioning
confidence: 99%
“…Poor wall-apposition has been described as a predictive factor for immediate instent and delayed thrombosis after stents use [ 6 ]. In this sense, precise measurement and device selection are mandatory steps when considering flow diverter usage in order to avoid potential complications [ 7 , 8 ].…”
Section: Discussionmentioning
confidence: 99%